![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 1280-1284, March 2003
Department of Medicine (V.K.G., E.J.S.) and Department of
Physiology and Biophysics (V.K.G., S.D.A., E.J.S.), University of
Alabama at Birmingham, Birmingham, Alabama; Southern Research Institute
(W.R.W., P.W.A., W.B.P.), Birmingham, Alabama
We have demonstrated antitumor activity against refractory human glioma
and pancreatic tumors with 6-methylpurine (MeP) using either a suicide
gene therapy strategy to selectively release 6-methylpurine in tumor
cells or direct intratumoral injection of 6-methylpurine itself. A
single i.p. injection in mice of the prodrug
9-
-D-[2-deoxyribofuranosyl]-6-methylpurine (MeP-dR;
134 mg/kg) caused sustained regression lasting over 70 days of D54 (human glioma) tumors transduced with the Escherichia
coli purine nucleoside phosphorylase (PNP), and a single
intratumoral injection of 6-methylpurine (5-10 mg/kg) elicited
prolonged delays of the growth of D54 tumors and CFPAC human pancreatic
carcinoma. Because the D54 tumor doubling time is >15 days, the
experiments indicate that prodrug activation by E.
coli PNP engenders destruction of both dividing and
nondividing tumor compartments in vivo and, therefore, address a
fundamental barrier that has limited the development of suicide gene
strategies in the past. A prolonged retention time of 6-methylpurine
metabolites in tumors was noted in vivo
(T1/2 >24 h compared with a serum half-life
of <1 h). By high-pressure liquid chromatography, metabolites
of [3H]MeP-dR were 5- to 6-fold higher in tumors
expressing E. coli PNP. These experiments
point to new endpoints for monitoring E. coli PNP suicide gene therapy, including intratumoral
enzymatic activity, in situ (intratumoral) prodrug conversion, and
tumor regressions after direct injection of a suicide gene toxin. The findings also help explain the strong in vivo bystander killing mechanism ascribed by several laboratories to E.
coli PNP in the past.
This article has been cited by other articles:
![]() |
J.-W. Ting, M.-F. Wu, C.-T. Tsai, C.-C. Lin, I.-C. Guo, and C.-Y. Chang Identification and characterization of a novel gene of grouper iridovirus encoding a purine nucleoside phosphorylase J. Gen. Virol., October 1, 2004; 85(10): 2883 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hong, W. R. Waud, D. N. Levasseur, T. M. Townes, H. Wen, S. A. McPherson, B. A. Moore, Z. Bebok, P. W. Allan, J. A. Secrist III, et al. Excellent In vivo Bystander Activity of Fludarabine Phosphate against Human Glioma Xenografts that Express the Escherichia coli Purine Nucleoside Phosphorylase Gene Cancer Res., September 15, 2004; 64(18): 6610 - 6615. [Abstract] [Full Text] [PDF] |
||||